These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12514149

  • 1. Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials.
    Gilron I, Bailey JM.
    Can J Anaesth; 2003 Jan; 50(1):42-7. PubMed ID: 12514149
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jan; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 4. Management of neuropathic pain.
    Jensen TS, Finnerup NB.
    Curr Opin Support Palliat Care; 2007 Aug; 1(2):126-31. PubMed ID: 18685353
    [Abstract] [Full Text] [Related]

  • 5. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
    Nwokeji ED, Rascati KL, Brown CM, Eisenberg A.
    Clin Ther; 2007 Aug; 29 Suppl():2589-602. PubMed ID: 18164924
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L, Manchikanti KN, Pampati V, Cash KA.
    Pain Physician; 2009 Aug; 12(1):259-67. PubMed ID: 19165308
    [Abstract] [Full Text] [Related]

  • 7. Patients' attitudes and prior treatments in neuropathic pain: a pilot study.
    Gilron I, Bailey J, Weaver DF, Houlden RL.
    Pain Res Manag; 2002 Aug; 7(4):199-203. PubMed ID: 12518177
    [Abstract] [Full Text] [Related]

  • 8. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco.
    Potter M, Schafer S, Gonzalez-Mendez E, Gjeltema K, Lopez A, Wu J, Pedrin R, Cozen M, Wilson R, Thom D, Croughan-Minihane M.
    J Fam Pract; 2001 Feb; 50(2):145-51. PubMed ID: 11219563
    [Abstract] [Full Text] [Related]

  • 9. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
    Rauck RL.
    Pain Pract; 2009 Feb; 9(6):468-79. PubMed ID: 19874536
    [Abstract] [Full Text] [Related]

  • 10. Survey of opioid use in chronic nonmalignant pain patients.
    Jamison RN, Anderson KO, Peeters-Asdourian C, Ferrante FM.
    Reg Anesth; 1994 Feb; 19(4):225-30. PubMed ID: 7947421
    [Abstract] [Full Text] [Related]

  • 11. Oral opioid therapy for chronic peripheral and central neuropathic pain.
    Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D.
    N Engl J Med; 2003 Mar 27; 348(13):1223-32. PubMed ID: 12660386
    [Abstract] [Full Text] [Related]

  • 12. Chronic pain management issues in the primary care setting and the utility of long-acting opioids.
    Zorba Paster R.
    Expert Opin Pharmacother; 2010 Aug 27; 11(11):1823-33. PubMed ID: 20629606
    [Abstract] [Full Text] [Related]

  • 13. Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids.
    Duensing L, Eksterowicz N, Macario A, Brown M, Stern L, Ogbonnaya A.
    Curr Med Res Opin; 2010 Jul 27; 26(7):1579-85. PubMed ID: 20429822
    [Abstract] [Full Text] [Related]

  • 14. Prevalence, etiology, and management of neuropathic pain in an Indian cancer hospital.
    Jain PN, Chatterjee A, Choudhary AH, Sareen R.
    J Pain Palliat Care Pharmacother; 2009 Jul 27; 23(2):114-9. PubMed ID: 19492212
    [Abstract] [Full Text] [Related]

  • 15. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L.
    Pain Physician; 2008 Mar 27; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [Abstract] [Full Text] [Related]

  • 16. Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.
    Wolfert MZ, Gilson AM, Dahl JL, Cleary JF.
    Pain Med; 2010 Mar 27; 11(3):425-34. PubMed ID: 20002590
    [Abstract] [Full Text] [Related]

  • 17. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB, Zwemer FL, Hays DP, Feng C.
    Acad Emerg Med; 2009 Jun 27; 16(6):477-87. PubMed ID: 19426295
    [Abstract] [Full Text] [Related]

  • 18. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management.
    Fine PG, Mahajan G, McPherson ML.
    Pain Med; 2009 Jul 27; 10 Suppl 2():S79-88. PubMed ID: 19691687
    [Abstract] [Full Text] [Related]

  • 19. Palliative care. Some organisational considerations.
    Welshman A.
    Minerva Anestesiol; 2005 Jul 27; 71(7-8):439-43. PubMed ID: 16012417
    [Abstract] [Full Text] [Related]

  • 20. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug 27; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.